Drug intelligence / Profile preview

Shengxuexiaoban

Development stage
Unknown
Lead developer
Haoqijun
Modality
Small Molecules
Administration
Oral
01

Overview

Shengxuexiaoban is a traditional Chinese medicine formula widely used in China for the treatment of primary immune thrombocytopenia (ITP), also known as idiopathic thrombocytopenic purpura. It is composed of natural indigo, cortex moutan (Moutan bark), forsythia, herba agrimoniae (Agrimony herb), and licorice. The formulation is designed to clear heat and detoxify the blood, cool the blood, stop bleeding, and dissipate stasis according to traditional Chinese medicine principles[2][6]. Modern pharmacological studies indicate that it can increase platelet counts by suppressing immune function and reducing platelet antibody production[1][6]. Mechanistically, it may block the interaction between platelet antibody-antigen complexes and Fc receptors on macrophages—thereby reducing phagocytosis—and modulate signaling pathways such as PI3K-AKT-mTOR involved in B cell and T cell regulation[6][8]. Network pharmacology studies suggest effects on transcription regulation, cell proliferation/differentiation (especially megakaryocytes), apoptosis processes via PI3K-AKT signaling pathway modulation[8]. It has also been reported to inhibit angiogenesis in vitro in ovarian cancer models[5].

Brand names
Sheng-Xue-Xiao-Ban Capsule
Other names
Shengxuexiaoban CapsulesSheng-xue-xiao-ban capsuleSC
02

Targets

VEGFR2 (Vascular endothelial growth factor receptor 2)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)STAT3 (Signal Transducer and Activator of Transcription 3)mTOR (Mammalian target of rapamycin kinase)

Beyond the preview

Go deeper on Shengxuexiaoban.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shengxuexiaoban.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call